Table 3.
Paediatricians’ approaches to discussing the HPV vaccine, stratified by whether or not they would encourage the vaccine for all eligible patients.
| Which of the following best summarizes how you would likely discuss the HPV vaccine? | All respondents (N = 332),*,† n (%) | Those who will recommend the vaccine for all of their patients (N = 290), n (%)† | Those who will recommend the vaccine for some/none of patients (N = 40), n (%)† |
|---|---|---|---|
| I will not encourage the vaccine at this time | 4 (1) | 3 (1) | 1 (3) |
| I will recommend the vaccine and try to persuade those who are reluctant | 247 (74) | 232 (80) | 15 (38) |
| I will offer the vaccine, but I will not try to persuade one way or the other | 52 (16) | 32 (11) | 18 (45) |
| I will not promote the vaccine, but if asked, I will discuss it and provide it | 6 (2) | 2 (1) | 4 (10) |
| I will not promote the vaccine, but if asked, I will refer to another physician or practice | 1 (<1) | 1 (<1) | 0 (0) |
| I will not promote the vaccine, and if asked, I will try to discourage its use | 0 (0) | 0 (0) | 0 (0) |
| Other | 22 (7) | 20 (7) | 2 (5) |
P<0.001 (χ2) for this comparison (differences in discussion strategies by differences in recommendations).
*
N counts do not all sum to the total due to partial non-response.
†
Percentages do not add up to 100 due to rounding error.